Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Invictus MD Strategies Corp IVITF

Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.


GREY:IVITF - Post by User

Comment by gamos99on Sep 30, 2019 2:54am
209 Views
Post# 30176404

RE:RE:RE:RE:Invictus revenues 415% over same quarter last year

RE:RE:RE:RE:Invictus revenues 415% over same quarter last year


$2.5M quarterly revenue is great but not happy about the big net loss. The cost of getting rid of Gene Simmosn and Canandia = $9 million ( I think you call these goodwill writedowns, i.e. the potential value of the company was lowered). You can kind of look past the GS and Canandia stuff, but concerned that the regular costs are still so high.

 

But with better revs. (certain due to oil sales and increased Ontario sales) and lower costs next, I believe GENE will become profitable within 2 quarters.

Bad moves from Kriznic and Kveton still haunting the company though.

<< Previous
Bullboard Posts
Next >>